Oral maxillofacial disease
Conditions
Interventions
NHF equipment with air administration group
respiratory management without device group
Face mask with oxygen administration group
Sponsors
Ayuse Takao
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Age: Adult patients aged 18 to 85 years of age at the time of consent acquisition 2 Gender: Any question 3 hospitalization / outpatient: hospitalization only 4 Patients who received written consent by their own free will after thorough understanding before participating in this study
Exclusion criteria
Exclusion criteria: 1) Patients who have already been receiving continuous oxygen (home oxygen therapy) by nasal cannula 2) Patients who cannot breathe nose 3) Patients who cannot reduce or discontinue antithrombotic drugs after surgery 4) Patients with a history of pneumothorax 5) Patients who need to administer drugs for pain control after surgery 6) Patients with significant postoperative morphological changes such as extensive resection of the jawbone 7) Other patients judged by the investigator to be inappropriate as study subjects 8) Patients who are positive for the new coronavirus (SARS-CoV-2) PCR test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Time-weighted average value of tcpO2 (average partial pressure during the observation period) 2) Time-weighted average value of tcpCO2 (average partial pressure during observation period) 3) SpO2 time-weighted average (average oxygen saturation during observation period) 4) respiratory rate time-weighted average (average respiratory rate during observation period) 5) The rate of occurrence of remarkably high CO2 blood serum in which tcpCO2 is 60 mmHg or more (equivalent to PaCO2> 55 mmHg) for 5 minutes or more 6) Incidence rate of moderate hyper CO2 blood with tcpCO2 of 50mmHg or more (equivalent to PaCO2> 45mmHg) 7) SpO2 decreased to 90% or less, requiring oxygen administration | — |
Contacts
Public ContactTakao Ayuse
Nagasaki University Hospital
Outcome results
None listed